PBH Prestige Consumer Healthcare Inc. Common Stock
NYSE · Pharmaceuticals · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 6, 2026
$45,26
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$42,62mínimo 52 semanas
$71,07máximo 52 semanas
Capitalización Bursátil (MRQ)
$2.55B
P/E (TTM)
12.7
BPA (TTM)
$3.57
Ingresos (TTM)
$1.10B
tus insignias
Rango 52S
$43–$71
Calificación del Analista
BUY
Precio Objetivo
$68
P/E
12.7
ROE
9.1%
Margen de Beneficio Neto
15.6%
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
PBH Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$45.26
Capitalización Bursátil (MRQ)
$2.55B
P/E (TTM)
12.7
BPA (TTM)
$3.57
Ingresos (TTM)
$1.10B
ROE (TTM)
9.1%
Deuda/Capital (MRQ)
1.1
Rango 52S
$43–$71
PBH Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Acerca de Prestige Consumer Healthcare Inc. Common Stock Descripción general de la empresa de Wikipedia
Prestige Consumer Healthcare Inc. (formerly Prestige Brands, Inc.) is an American company that markets and distributes over-the-counter healthcare and household cleaning products. It was formed by the merger of Medtech Products, Inc., Prestige Brands International, and the Spic and Span Company in 1996. The company is headquartered in Tarrytown, New York and operates a manufacturing facility in Lynchburg, Virginia.
Among the brands owned by Prestige are Chloraseptic sore throat products, Clear Eyes, Compound W wart treatment, Dramamine motion sickness treatment, Efferdent denture care, Luden's throat drops, BC Powder and Goody's Headache Powder, Pediacare & Little Remedies children's OTC products and Beano (dietary supplement).
The company's CEO and president is Ron Lombardi, who replaced Matthew Mannelly on June 1, 2015.
History
Prestige Brands Holdings, Inc. was established in 1999 to acquire, revitalize, and line extend leading, often neglected but healthy brands that were considered non-core at major consumer products companies. In 2004, MidOcean Partners sold Prestige Brands to GTCR Golder Rauner.
Acquisitions
The company acquired Blacksmith Brands' portfolio of five brands in 2010.
In December 2011, the company agreed to purchase 17 brands from GlaxoSmithKline including BC Powder, Beano, Ecotrin, Fiber Choice, Goody's Powder, Sominex and Tagamet for $660 million.
In 2013, Prestige Brands Holdings, Inc. acquired Care Pharmaceuticals of Bondi Junction, New South Wales, Australia, a privately held marketer and distributor of over-the-counter (OTC) healthcare brands for children and adults.
In 2014, the company purchased Hydralyte in Australia and New Zealand from the Hydration Pharmaceuticals Trust of Victoria, Australia. Hydralyte is the leading oral rehydration product in Australia and New Zealand.
In April 2014, Prestige Brands Holdings, Inc. announced that it has entered into a definitive agreement to acquire Insight Pharmaceuticals Corporation, a marketer and distributor of feminine care and other over-the-counter healthcare products, for $750 million in cash.
In November 2015, Prestige Brands Holdings, Inc. announced that it has entered into a definitive agreement to acquire DenTek Oral Care Inc. (DenTek), a privately held marketer and distributor of oral care products for $225 million in cash.
In December 2016, Prestige Brands Holdings, Inc. agreed to buy C.B. Fleet Co. from private-equity firm Gryphon Investors for about $825 million.
In July 2021, consumer health business assets were acquired from Akorn Operating Company, LLC for $228.9 million adding TheraTears and other products to their brands.
Divestitures
In 2009, Prestige sold its Denorex and Prell brands of shampoo. It has since divested Fiber Choice, PediaCare, New-Skin, and Dermoplast (2016).
In 2018, Prestige sold off their household cleaning supply division.
Products
Prestige Consumer Healthcare owns many over-the counter medicines and products, including:
Fuente: Wikipedia (Inglés), CC BY-SA 4.0 · Ver en Wikipedia ↗
sectorHealthcare
industriaPharmaceuticals
empleados890
paísUS
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos$1.09B2017-03-31 → 2026-03-31
BPA$3.912017-03-31 → 2026-03-31
Flujo de caja libre$246M2017-03-31 → 2026-03-31
Margen neto15.6%2017-03-31 → 2026-03-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | PBH | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E (TTM) | 12.7promedio 5A ≈5.5 | ≈5.5 | · | · | |
| P/S (TTM) | 2.3promedio 5A ≈3.3 | ≈3.3 | · | · | |
| P/C (MRQ) | 1.3promedio 5A ≈2.2 | ≈2.2 | · | · | |
| Precio / FCF (TTM) | 10.8promedio 5A ≈15.4 | ≈15.4 | · | · | |
| Precio / Flujo de Caja (TTM) | 10.2promedio 5A ≈14.9 | ≈14.9 | · | · | |
| Precio / Valor Contable Tangible (MRQ) | -1.9 | · | · | · | |
| PEG Ratio (Ratio PEG) | ≈3.4 | · | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | PBH | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Margen Bruto (TTM) | 53.5%promedio 5A ≈55.7% | ≈55.7% | · | · | |
| Margen Operativo (TTM) | 26.3%promedio 5A ≈23.4% | ≈23.4% | · | · | |
| Margen EBITDA (TTM) | 29.2%promedio 5A ≈26.2% | ≈26.2% | · | · | |
| Pretax Margin (Margen antes de impuestos) | 23.6%promedio 5A ≈17.8% | ≈17.8% | · | · | |
| Margen de Beneficio Neto (TTM) | 15.6%promedio 5A ≈13.3% | ≈13.3% | · | · | |
| ROA (TTM) | 4.3%promedio 5A ≈4.3% | ≈4.3% | · | · | |
| ROE (TTM) | 9.1%promedio 5A ≈8.6% | ≈8.6% | · | · | |
| ROIC | 12.1%promedio 5A ≈8.6% | ≈8.6% | · | · |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | PBH | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Deuda / Patrimonio (MRQ) | 1.1promedio 5A ≈0.8 | ≈0.8 | · | · | |
| Ratio corriente (MRQ) | 3.2promedio 5A ≈3.1 | ≈3.1 | · | · | |
| Quick Ratio (Ratio Rápido) | 2.1promedio 5A ≈1.9 | ≈1.9 | · | · | |
| Deuda a Largo Plazo / Patrimonio (MRQ) | 1.0promedio 5A ≈0.8 | ≈0.8 | · | · |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
| Métrica | Tendencia a 5 años | PBH | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Revenue YoY (Ingresos interanuales) | -4.3%promedio 5A ≈3.1% | ≈3.1% | · | · | |
| Revenue CAGR 3Y (Ingresos CAGR 3A) | -1.2%promedio 5A ≈2.1% | ≈2.1% | · | · | |
| Revenue CAGR 5Y (Ingresos CAGR 5A) | 2.9% | · | · | · | |
| EPS YoY (EPS interanual) | -8.9%promedio 5A ≈6.1% | ≈6.1% | · | · | |
| Net Income YoY (Beneficio Neto interanual) | -11.3%promedio 5A ≈5.3% | ≈5.3% | · | · | |
| EPS CAGR 3Y (CAGR BPA 3A) | 2.0% | · | · | · | |
| EPS CAGR 5Y (CAGR BPA 5A) | 3.8% | · | · | · | |
| Net Income CAGR 3Y (CAGR Beneficio Neto 3A) | 1.5% | · | · | · | |
| Net Income CAGR 5Y (CAGR Beneficio Neto 5A) | 2.9% | · | · | · |
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | PBH | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Asset Turnover (Rotación de Activos) | 0.3promedio 5A ≈0.3 | ≈0.3 | · | · | |
| Inventory Turnover (Rotación de Inventario) | 3.2promedio 5A ≈3.5 | ≈3.5 | · | · | |
| Receivables Turnover (Rotación de Cuentas por Cobrar) | 5.6promedio 5A ≈6.8 | ≈6.8 | · | · | |
| Revenue / Employee (Ingresos / Empleado) | ≈$1.2M | · | · | · |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
0.02%
Próximo informe
Nov 04, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | $0.98 | $0.89 | 10.0% | |
| 31 de marzo de 2026 | $1.23 | $1.40 | -12.4% | |
| 31 de diciembre de 2025 | $1.14 | $1.16 | -1.4% | |
| 30 de septiembre de 2025 | $1.07 | $0.98 | 9.2% | |
| 30 de junio de 2025 | $0.95 | $1.01 | -6.0% | |
| 31 de marzo de 2025 | $1.32 | $1.31 | 0.64% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.09B | $1.14B | $1.13B | $1.13B | $1.09B | $943M | $963M | $976M | $1.04B | $882M | $806M | $715M | |
| Cost of Revenue | $493M | $503M | $501M | $502M | $466M | $396M | $411M | $420M | $465M | $382M | $339M | · | |
| Gross Profit | $596M | $634M | $624M | $625M | $621M | $547M | $552M | $556M | $577M | $500M | $467M | $406M | |
| SG&A Expense | $116M | $108M | $106M | $107M | $107M | $83M | $89M | $90M | $85M | $89M | $72M | $81M | |
| Operating Expenses | $286M | $298M | $282M | $648M | $291M | $250M | $261M | $488M | $361M | $295M | $207M | $199M | |
| Operating Income | $309M | $337M | $342M | $-22M | $330M | $297M | $291M | $68M | $215M | $206M | $260M | $208M | |
| Interest Expense | · | $2M | $5M | $4M | · | · | · | · | · | · | · | · | |
| Interest Income | · | · | · | · | · | · | $342.0K | $217.0K | $388.0K | $203.0K | $162.0K | $92.0K | |
| Other Non-op | $-10M | $-5M | $756.0K | $-2M | $-1M | $1M | $-2M | $-476.0K | $392.0K | $-30.0K | · | · | |
| Pretax Income | $257M | $284M | $276M | $-94M | $262M | $204M | $191M | $-38M | $107M | $111M | $157M | $127M | |
| Income Tax | $67M | $70M | $67M | $-12M | $57M | $39M | $49M | $-2M | $-232M | $41M | $57M | $49M | |
| Net Income | $190M | $215M | $209M | $-82M | $205M | $165M | $142M | $-36M | $340M | $69M | $100M | $78M | |
| EPS (Basic) | $3.93 | $4.32 | $4.21 | $-1.65 | $4.09 | $3.28 | $2.81 | $-0.69 | $6.40 | $1.31 | $1.89 | $1.50 | |
| EPS (Diluted) | $3.91 | $4.29 | $4.17 | $-1.65 | $4.04 | $3.25 | $2.78 | $-0.69 | $6.34 | $1.30 | $1.88 | $1.49 | |
| Shares (Basic) | 48,456,000 | 49,697,000 | 49,757,000 | 49,889,000 | 50,259,000 | 50,210,000 | 50,723,000 | 52,068,000 | 53,099,000 | 52,976,000 | 52,754,000 | 52,170,000 | |
| Shares (Diluted) | 48,720,000 | 50,080,000 | 50,178,000 | 49,889,000 | 50,842,000 | 50,605,000 | 51,140,000 | 52,068,000 | 53,526,000 | 53,362,000 | 53,143,000 | 52,670,000 | |
| EBITDA | $341M | $367M | $373M | $10M | $362M | $328M | $320M | $99M | $249M | $231M | $284M | $225M |
Balance general
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $64M | $98M | $46M | $58M | $27M | $32M | $95M | $28M | $33M | $42M | $27M | $21M | |
| Receivables | $192M | $194M | $177M | $167M | $139M | $115M | $151M | $149M | $141M | $137M | $95M | $88M | |
| Inventory | $159M | $148M | $139M | $162M | $120M | $115M | $116M | $120M | $119M | $116M | $91M | $74M | |
| Prepaid Expense | $17M | $8M | $13M | $4M | $6M | $8M | $4M | $5M | $12M | $40M | $25M | $10M | |
| Current Assets | $431M | $448M | $375M | $392M | $293M | $270M | $366M | $301M | $303M | $334M | $249M | $202M | |
| PP&E (Net) | $122M | $75M | $77M | $70M | $71M | $70M | $56M | $51M | $53M | $51M | $16M | $14M | |
| PP&E (Gross) | $211M | $156M | $149M | $137M | $132M | $124M | $102M | $90M | $83M | $71M | $30M | $26M | |
| Accum. Depreciation | $89M | $81M | $72M | $67M | $61M | $54M | $46M | $39M | $30M | $20M | $15M | $12M | |
| Goodwill | $581M | $527M | $528M | $528M | $579M | $578M | $575M | $579M | $620M | $615M | $360M | $291M | |
| Intangibles | $2.30B | $2.30B | $2.32B | $2.34B | $2.70B | $2.48B | $2.48B | $2.51B | $2.78B | $2.90B | $2.32B | $2.13B | |
| Other Non-current Assets | $11M | $3M | $6M | $3M | $3M | $3M | $3M | $3M | $4M | $7M | $1M | $1M | |
| Total Assets | $3.49B | $3.40B | $3.32B | $3.35B | $3.67B | $3.43B | $3.51B | $3.44B | $3.76B | $3.91B | $2.95B | $2.64B | |
| Accounts Payable | $23M | $19M | $39M | $63M | $56M | $46M | $62M | $57M | $61M | $70M | $38M | $46M | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | · | · | $41M | |
| Current Liabilities | $121M | $107M | $117M | $161M | $143M | $122M | $150M | $127M | $123M | $162M | $107M | $99M | |
| Capital Leases | $21M | $23M | $8M | $10M | $16M | $20M | $25M | $0 | · | · | · | · | |
| Deferred Tax | $447M | $420M | $404M | $380M | $445M | $434M | $408M | $400M | $443M | $715M | $470M | $352M | |
| Other Non-current Liabilities | $6M | $5M | $9M | $8M | $7M | $9M | $25M | $20M | $23M | $18M | $3M | $2M | |
| Total Liabilities | $1.61B | $1.57B | $1.66B | $1.91B | $2.09B | $2.07B | $2.34B | $2.35B | $2.58B | $3.09B | $2.20B | $2.01B | |
| Long-term Debt | $994M | $992M | $1.13B | $1.35B | $1.48B | $1.48B | $1.73B | $1.80B | $1.99B | · | · | $1.56B | |
| Total Debt | · | · | $1.13B | $1.35B | $1.48B | $1.48B | $1.73B | $1.80B | $1.99B | $2.19B | $1.63B | $1.59B | |
| Common Stock | $562.0K | $560.0K | $555.0K | $548.0K | $544.0K | $540.0K | $538.0K | $536.0K | $534.0K | $533.0K | $530.0K | $525.0K | |
| Paid-in Capital | $609M | $593M | $567M | $535M | $516M | $500M | $488M | $479M | $469M | $458M | $445M | $427M | |
| Retained Earnings | $1.75B | $1.56B | $1.34B | $1.13B | $1.21B | $1.01B | $844M | $702M | $736M | $397M | $327M | $227M | |
| Treasury Stock | $439M | $277M | $220M | $189M | $134M | $131M | $118M | $60M | $8M | $7M | $5M | $3M | |
| AOCI | $-28M | $-38M | $-34M | $-32M | $-19M | $-20M | $-44M | $-26M | $-19M | $-26M | $-24M | $-23M | |
| Stockholders' Equity | $1.89B | $1.83B | $1.66B | $1.45B | $1.58B | $1.36B | $1.17B | $1.10B | $1.18B | $823M | $744M | $628M | |
| Liabilities + Equity | $3.49B | $3.40B | $3.32B | $3.35B | $3.67B | $3.43B | $3.51B | $3.44B | $3.76B | $3.91B | $2.95B | $2.64B | |
| Shares Outstanding | 56,211,000 | 56,010,000 | 55,501,000 | 54,857,000 | 54,430,000 | 53,999,000 | 53,805,000 | 53,670,000 | 53,396,000 | 53,287,000 | 53,066,000 | 52,562,000 |
Flujo de Efectivo
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $31M | $30M | $31M | $33M | $32M | $30M | $29M | $32M | $33M | $26M | $24M | $18M | |
| Stock-based Comp | $11M | $11M | $14M | $12M | · | · | · | · | · | $8M | $10M | $7M | |
| Deferred Tax | $23M | $14M | $23M | $-61M | $10M | $19M | $14M | $-41M | $-269M | $-6M | $46M | $29M | |
| Amort. of Intangibles | $18M | $18M | $20M | $22M | $21M | $20M | $20M | $22M | $23M | $20M | $18M | $13M | |
| Other Non-cash | $3M | $-19M | $-14M | $340M | $12M | $22M | $32M | $234M | $106M | $50M | $-5M | $24M | |
| Operating Cash Flow | $258M | $252M | $249M | $230M | $260M | $236M | $217M | $189M | $210M | $149M | $176M | $156M | |
| CapEx | $11M | $8M | $10M | $8M | $10M | $22M | $15M | $10M | $13M | $3M | $4M | $6M | |
| Investing Cash Flow | $-137M | $-17M | $-20M | $-12M | $-257M | $-22M | $-17M | $55M | $-12M | $-695M | $-223M | $-805M | |
| Stock Repurchased | $156M | $52M | $25M | $50M | $0 | $12M | $57M | $50M | $0 | $0 | · | · | |
| Net Stock Activity | $-156M | $-52M | $-25M | $-50M | $0 | $-12M | $-57M | $-50M | · | · | · | · | |
| Dividends Paid | · | · | · | · | · | · | · | · | · | · | $0 | $0 | |
| Financing Cash Flow | $-156M | $-182M | $-241M | $-186M | $-8M | $-279M | $-131M | $-249M | $-209M | $561M | $52M | $643M | |
| Net Change in Cash | $-34M | $51M | $-12M | $31M | $-5M | $-62M | $67M | $-5M | $-9M | $15M | $6M | $-7M | |
| Taxes Paid | $46M | · | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $246M | $243M | $239M | $222M | $250M | $213M | $203M | $179M | $198M | $145M | $171M | $150M | |
| Levered FCF | · | $242M | $235M | · | · | · | · | · | · | · | · | · |
Rentabilidad
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 54.7% | 55.8% | 55.5% | 55.5% | 57.1% | 58.0% | 57.3% | 56.9% | 55.4% | 56.7% | 58.0% | 56.9% | |
| Operating Margin | 28.4% | 29.6% | 30.4% | -2.0% | 30.4% | 31.5% | 30.2% | 6.9% | 20.7% | 23.3% | 32.3% | 29.1% | |
| Net Margin | 17.5% | 18.9% | 18.6% | -7.3% | 18.9% | 17.5% | 14.8% | -3.7% | 32.6% | 7.9% | 12.4% | 11.0% | |
| Pretax Margin | 23.6% | 25.0% | 24.5% | -8.3% | 24.1% | 21.6% | 19.9% | -3.9% | 10.3% | 12.6% | 19.5% | 17.9% | |
| EBITDA Margin | 31.3% | 32.2% | 33.1% | 0.91% | 33.3% | 34.7% | 33.2% | 10.2% | 23.9% | 26.2% | 35.2% | 31.6% | |
| ROA | 5.5% | 6.4% | 6.3% | -2.3% | 5.8% | 4.7% | 4.1% | -0.99% | 8.8% | 2.0% | 3.6% | 3.5% | |
| ROE | 10.2% | 11.8% | 12.9% | -5.2% | 13.3% | 12.3% | 12.2% | -3.1% | 33.9% | 8.9% | 14.6% | 13.1% | |
| ROIC | 12.1% | 13.9% | 9.3% | -0.70% | 8.5% | 8.5% | 7.5% | 2.2% | 21.6% | 4.3% | 7.0% | 5.8% |
Liquidez y Solvencia
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.6 | 4.2 | 3.2 | 2.4 | 2.0 | 2.2 | 2.4 | 2.4 | 2.5 | 2.1 | 2.3 | 2.0 | |
| Quick Ratio | 2.1 | 2.7 | 1.9 | 1.4 | 1.2 | 1.2 | 1.6 | 1.4 | 1.4 | 1.1 | 1.1 | 1.1 | |
| Debt / Equity | · | · | 0.7 | 0.9 | 0.9 | 1.1 | 1.5 | 1.6 | 1.7 | 2.7 | 2.2 | 2.5 | |
| LT Debt / Equity | · | · | 0.7 | 0.9 | 0.9 | 1.1 | 1.5 | 1.6 | 1.7 | 2.7 | 2.2 | 2.5 | |
| Interest Coverage | · | 187.1 | 65.9 | · | · | · | · | · | · | · | · | · |
Eficiencia
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | |
| Inventory Turnover | 3.2 | 3.5 | 3.3 | 3.6 | 4.0 | 3.4 | 3.5 | 3.6 | 4.0 | · | · | · | |
| Receivables Turnover | 5.6 | 6.1 | 6.5 | 7.4 | 8.6 | 7.1 | 6.4 | 6.6 | 7.5 | 7.6 | 8.8 | 9.3 |
Por Acción
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $33.58 | $32.76 | $29.82 | $26.38 | $28.98 | $25.15 | $21.76 | $20.42 | $22.07 | $15.44 | $14.03 | $11.94 | |
| Revenue / Share | $22.35 | $22.72 | $22.43 | $22.60 | $21.38 | $18.64 | $18.83 | $18.74 | $19.45 | $16.53 | $15.17 | $13.55 | |
| Cash Flow / Share | $5.29 | $5.02 | $4.96 | $4.60 | $5.11 | $4.66 | $4.25 | $3.64 | $3.93 | $2.77 | $3.28 | $2.97 | |
| Cash / Share | $1.14 | $1.75 | $0.84 | $1.07 | $0.50 | $0.60 | $1.76 | $0.51 | $0.61 | $0.79 | $0.51 | $0.41 | |
| EPS (TTM) | $3.91 | $4.29 | $4.17 | $-1.65 | $4.04 | $3.25 | $2.78 | $-0.69 | $6.34 | $1.30 | $1.88 | $1.49 |
Tasas de Crecimiento
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -4.3% | 1.1% | -0.21% | 3.8% | 15.2% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -1.2% | 1.5% | 6.1% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 2.9% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -8.9% | 2.9% | · | · | 24.3% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | · | 2.0% | 8.7% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 3.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -11.3% | 2.5% | · | · | 24.7% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | · | 1.5% | 8.3% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 2.9% | · | · | · | · | · | · | · | · | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.09B | $1.14B | $1.13B | $1.13B | $1.09B | $943M | $963M | $976M | $1.04B | $882M | $806M | $715M | |
| Net Income TTM | $190M | $215M | $209M | $-82M | $205M | $165M | $142M | $-36M | $340M | $69M | $100M | $78M | |
| Market Cap | $3.33B | $4.82B | $4.03B | $3.44B | $2.88B | $2.38B | $1.97B | $1.61B | $1.80B | $2.96B | $2.83B | $2.25B | |
| Enterprise Value | · | · | $5.11B | $4.72B | $4.33B | $3.83B | $3.61B | $3.38B | $3.76B | $5.11B | $4.43B | $3.82B | |
| P/E | 15.2 | 20.0 | 17.4 | -38.0 | 13.1 | 13.6 | 13.2 | -43.3 | 5.3 | 42.7 | 28.4 | 28.8 | |
| P/S | 3.1 | 4.2 | 3.6 | 3.0 | 2.7 | 2.5 | 2.0 | 1.6 | 1.7 | 3.4 | 3.5 | 3.2 | |
| P/B | 1.8 | 2.6 | 2.4 | 2.4 | 1.8 | 1.8 | 1.7 | 1.5 | 1.5 | 3.6 | 3.8 | 3.6 | |
| P / Cash Flow | 12.9 | 19.1 | 16.2 | 15.0 | 11.1 | 10.1 | 9.1 | 8.5 | 8.6 | 20.0 | 16.2 | 14.4 | |
| P / FCF | 13.5 | 19.8 | 16.8 | 15.5 | 11.5 | 11.2 | 9.7 | 9.0 | 9.1 | 20.4 | 16.6 | 15.0 | |
| EV / EBITDA | · | · | 13.7 | 462.6 | 12.0 | 11.7 | 11.3 | 34.0 | 15.1 | 22.1 | 15.6 | 17.0 | |
| EV / FCF | · | · | 21.3 | 21.3 | 17.3 | 17.9 | 17.8 | 18.9 | 19.0 | 35.3 | 25.9 | 25.5 | |
| EV / Revenue | · | · | 4.5 | 4.2 | 4.0 | 4.1 | 3.7 | 3.5 | 3.6 | 5.8 | 5.5 | 5.3 | |
| Dividend Yield | · | · | · | · | · | · | · | · | · | · | 0.00% | 0.00% | |
| Earnings Yield | 6.6% | 5.0% | 5.8% | -2.6% | 7.6% | 7.4% | 7.6% | -2.3% | 18.8% | 2.3% | 3.5% | 3.5% | |
| Payout Ratio | · | · | · | · | · | · | · | · | · | · | 0.00% | 0.00% | |
| Annual Payout | · | · | · | · | · | · | · | · | · | · | $0 | $0 |
Estado de resultados
| Métrica | Tendencia | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $266M | $282M | $283M | $274M | $250M | $297M | $290M | $284M | $267M | $277M | $283M | $286M | $279M | $286M | $276M | $289M | |
| Cost of Revenue | $130M | $135M | $126M | $123M | $109M | $127M | $129M | $126M | $121M | $125M | $125M | $126M | $125M | $132M | $125M | $128M | |
| Gross Profit | $136M | $146M | $157M | $152M | $140M | $170M | $161M | $157M | $146M | $152M | $158M | $160M | $155M | $154M | $150M | $161M | |
| SG&A Expense | $43M | $30M | $30M | $28M | $28M | $27M | $26M | $26M | $29M | $26M | $26M | $26M | $28M | $28M | $27M | $26M | |
| Operating Expenses | $84M | $71M | $75M | $72M | $69M | $82M | $69M | $73M | $74M | $70M | $71M | $72M | $69M | $435M | $63M | $77M | |
| Operating Income | $53M | $75M | $82M | $80M | $72M | $88M | $92M | $84M | $72M | $82M | $87M | $88M | $85M | $-281M | $87M | $84M | |
| Other Non-op | $-34.0K | $708.0K | $-10M | $-501.0K | $224.0K | $-4M | $-353.0K | $-395.0K | $-496.0K | $429.0K | $-682.0K | $-229.0K | $1M | $451.0K | $-1M | $-812.0K | |
| Income Tax | $9M | $11M | $15M | $27M | $14M | $24M | $19M | $17M | $9M | $18M | $17M | $17M | $15M | $-59M | $16M | $16M | |
| Net Income | $29M | $54M | $47M | $42M | $47M | $50M | $61M | $54M | $49M | $49M | $53M | $54M | $53M | $-241M | $52M | $51M | |
| EPS (Basic) | $0.61 | $1.13 | $0.98 | $0.86 | $0.96 | $1.01 | $1.23 | $1.10 | $0.98 | $0.99 | $1.07 | $1.08 | $1.07 | $-4.82 | $1.05 | $1.02 | |
| EPS (Diluted) | $0.61 | $1.13 | $0.97 | $0.86 | $0.95 | $1.00 | $1.22 | $1.09 | $0.98 | $0.98 | $1.06 | $1.07 | $1.06 | $-4.80 | $1.04 | $1.02 | |
| Shares (Basic) | 47,462,000 | · | 47,880,000 | 49,025,000 | 49,475,000 | · | 49,597,000 | 49,652,000 | 49,886,000 | · | 49,740,000 | 49,687,000 | 49,767,000 | · | 49,693,000 | 49,804,000 | |
| Shares (Diluted) | 47,604,000 | · | 48,087,000 | 49,264,000 | 49,833,000 | · | 49,993,000 | 49,998,000 | 50,267,000 | · | 50,125,000 | 50,081,000 | 50,196,000 | · | 50,186,000 | 50,265,000 | |
| EBITDA | $61M | · | $82M | $80M | $79M | · | $92M | $84M | $80M | · | $87M | $88M | $93M | · | $87M | $84M |
Balance general
| Métrica | Tendencia | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $89M | $64M | $62M | $119M | $140M | $98M | $51M | $52M | $34M | $46M | $64M | $60M | $55M | · | $86M | $42M | |
| Receivables | $187M | $192M | $190M | $199M | $168M | $194M | $167M | $164M | $172M | $177M | $174M | $158M | $158M | · | $157M | $146M | |
| Inventory | $190M | $159M | $164M | $159M | $153M | $148M | $152M | $156M | $152M | $139M | $149M | $161M | $170M | · | $159M | $141M | |
| Prepaid Expense | $30M | $17M | $17M | $20M | $19M | $8M | $8M | $9M | $11M | $13M | $7M | $8M | $9M | · | $7M | $8M | |
| Current Assets | $497M | $431M | $433M | $497M | $481M | $448M | $377M | $381M | $369M | $375M | $394M | $388M | $392M | · | $409M | $337M | |
| PP&E (Net) | $117M | $122M | $128M | $73M | $74M | $75M | $74M | $75M | $75M | $77M | $70M | $71M | $70M | · | $70M | $70M | |
| PP&E (Gross) | · | $211M | · | · | · | $156M | · | · | · | $149M | · | · | · | · | · | · | |
| Accum. Depreciation | · | $89M | · | · | · | $81M | · | · | · | $72M | · | · | · | · | · | · | |
| Goodwill | $651M | $581M | $581M | $528M | $528M | $527M | $527M | $529M | $528M | $528M | $528M | $527M | $527M | $528M | $577M | $576M | |
| Intangibles | $3.24B | $2.30B | $2.30B | $2.29B | $2.29B | $2.30B | $2.31B | $2.32B | $2.32B | $2.32B | $2.33B | $2.33B | $2.34B | · | $2.67B | $2.67B | |
| Other Non-current Assets | $13M | $11M | $4M | $3M | $3M | $3M | $6M | $7M | $6M | $6M | $6M | $4M | $3M | · | $3M | $3M | |
| Total Assets | $4.57B | $3.49B | $3.49B | $3.44B | $3.43B | $3.40B | $3.33B | $3.32B | $3.31B | $3.32B | $3.34B | $3.33B | $3.35B | · | $3.75B | $3.68B | |
| Accounts Payable | $37M | $23M | $43M | $42M | $22M | $19M | $20M | $31M | $40M | $39M | $39M | $44M | $58M | · | $64M | $56M | |
| Current Liabilities | $154M | $121M | $140M | $135M | $110M | $107M | $103M | $107M | $114M | $117M | $127M | $130M | $147M | · | $160M | $152M | |
| Capital Leases | $19M | $21M | $18M | $20M | $21M | $23M | $24M | $7M | $7M | $8M | $6M | $7M | $8M | · | $12M | $13M | |
| Deferred Tax | $449M | $447M | $449M | $445M | $427M | $420M | $413M | $415M | $409M | $404M | $397M | $388M | $384M | · | $456M | $443M | |
| Other Non-current Liabilities | $6M | $6M | $6M | $5M | $5M | $5M | $5M | $5M | $5M | $9M | $9M | $9M | $8M | · | $9M | $9M | |
| Total Liabilities | $2.65B | $1.61B | $1.67B | $1.62B | $1.58B | $1.57B | $1.54B | $1.59B | $1.63B | $1.66B | $1.74B | $1.80B | $1.87B | · | $2.06B | $2.06B | |
| Long-term Debt | $2.02B | $994M | $1.03B | $993M | $993M | $992M | $992M | $1.05B | $1.09B | $1.13B | $1.20B | $1.26B | $1.32B | · | $1.42B | $1.44B | |
| Total Debt | $2.02B | · | · | · | · | · | $1.00B | $1.06B | $1.10B | · | $1.21B | $1.27B | $1.33B | · | $1.44B | $1.46B | |
| Common Stock | $563.0K | $562.0K | $562.0K | $562.0K | $561.0K | $560.0K | $559.0K | $557.0K | $557.0K | $555.0K | $553.0K | $552.0K | $552.0K | · | $548.0K | $547.0K | |
| Paid-in Capital | $613M | $609M | $605M | $603M | $600M | $593M | $588M | $577M | $573M | $567M | $556M | $552M | $547M | · | $533M | $524M | |
| Retained Earnings | $1.78B | $1.75B | $1.69B | $1.65B | $1.60B | $1.56B | $1.51B | $1.44B | $1.39B | $1.34B | $1.29B | $1.24B | $1.19B | · | $1.37B | $1.32B | |
| Treasury Stock | $442M | $439M | $439M | $392M | $316M | $277M | $266M | $263M | $252M | $220M | $220M | $220M | $220M | · | $189M | $189M | |
| AOCI | $-30M | $-28M | $-30M | $-32M | $-32M | $-38M | $-40M | $-27M | $-31M | $-34M | $-29M | $-36M | $-32M | · | $-29M | $-36M | |
| Stockholders' Equity | $1.92B | $1.89B | $1.83B | $1.82B | $1.86B | $1.83B | $1.79B | $1.73B | $1.68B | $1.66B | $1.60B | $1.54B | $1.48B | $1.45B | $1.69B | $1.62B | |
| Liabilities + Equity | $4.57B | $3.49B | $3.49B | $3.44B | $3.43B | $3.40B | $3.33B | $3.32B | $3.31B | $3.32B | $3.34B | $3.33B | $3.35B | · | $3.75B | $3.68B | |
| Shares Outstanding | 56,312,000 | 56,211,000 | 56,198,000 | 56,196,000 | 56,171,000 | 56,010,000 | 55,939,000 | 55,769,000 | 55,717,000 | 55,501,000 | 55,329,000 | 55,291,000 | 55,220,000 | 54,857,000 | 54,852,000 | 54,690,000 |
Flujo de Efectivo
| Métrica | Tendencia | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $9M | $8M | $8M | $8M | $8M | $7M | $7M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | |
| Stock-based Comp | $4M | $3M | $3M | $2M | $4M | $3M | $3M | $2M | $3M | $4M | $2M | $4M | $4M | $3M | $2M | $3M | |
| Deferred Tax | $193.0K | $-4M | $4M | $17M | $6M | $7M | $3M | $4M | $612.0K | $8M | $5M | $5M | $4M | $-75M | $10M | $3M | |
| Amort. of Intangibles | $5M | $5M | $4M | $4M | $4M | $4M | $4M | $5M | $5M | $5M | $5M | $5M | $5M | · | $6M | $6M | |
| Other Non-cash | $29M | · | · | · | $14M | · | · | · | $-6M | · | · | · | $-21M | · | · | · | |
| Operating Cash Flow | $71M | $43M | $78M | $57M | $79M | $62M | $65M | $70M | $55M | $67M | $71M | $62M | $48M | $59M | $55M | $58M | |
| CapEx | $4M | $5M | $3M | $2M | $838.0K | $3M | $2M | $2M | $1M | $3M | $2M | $3M | $1M | $3M | $2M | $2M | |
| Investing Cash Flow | $-1.06B | $-3M | $-129M | $-3M | $-2M | $-3M | $-10M | $-2M | $-2M | $-15M | $-4M | $-3M | $2M | $-6M | $-2M | $-2M | |
| Debt Issued | $1.04B | · | · | · | $0 | · | · | · | · | · | · | · | · | · | · | · | |
| Net Debt Issued | $1.04B | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Stock Repurchased | $0 | $690.0K | $46M | $75M | $35M | $11M | $2M | $12M | $26M | $0 | $0 | $0 | $25M | $0 | $0 | $12M | |
| Net Stock Activity | $0 | · | · | · | $-35M | · | · | · | $-26M | · | · | · | $-25M | · | · | · | |
| Financing Cash Flow | $1.02B | $-38M | $-7M | $-75M | $-36M | $-11M | $-54M | $-51M | $-66M | $-68M | $-65M | $-54M | $-54M | $-80M | $-10M | $-48M | |
| Net Change in Cash | $25M | $1M | $-57M | $-20M | $42M | $47M | $-666.0K | $17M | $-12M | $-17M | $4M | $5M | $-4M | $-28M | $44M | $7M | |
| Free Cash Flow | $67M | · | · | · | $78M | · | · | · | $54M | · | · | · | $47M | · | · | · |
Rentabilidad
| Métrica | Tendencia | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 51.2% | · | 55.5% | 55.3% | 56.2% | · | 55.5% | 55.5% | 54.7% | · | 55.9% | 55.9% | 55.4% | · | 54.6% | 55.7% | |
| Operating Margin | 19.8% | · | 29.1% | 29.1% | 28.8% | · | 31.7% | 29.7% | 27.0% | · | 30.7% | 30.8% | 30.5% | · | 31.6% | 29.2% | |
| Net Margin | 11.0% | · | 16.5% | 15.4% | 19.0% | · | 21.0% | 19.2% | 18.4% | · | 18.8% | 18.7% | 19.1% | · | 18.9% | 17.6% | |
| EBITDA Margin | 23.1% | · | 29.1% | 29.1% | 31.8% | · | 31.7% | 29.7% | 30.0% | · | 30.7% | 30.8% | 33.2% | · | 31.6% | 29.2% | |
| ROA | 0.73% | · | 1.4% | 1.2% | 1.4% | · | 1.8% | 1.6% | 1.5% | · | 1.5% | 1.5% | 1.5% | · | 1.4% | 1.4% | |
| ROE | 1.6% | · | 2.6% | 2.4% | 2.7% | · | 3.6% | 3.3% | 3.1% | · | 3.2% | 3.4% | 3.5% | · | 3.2% | 3.3% |
Liquidez y Solvencia
| Métrica | Tendencia | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.2 | · | 3.1 | 3.7 | 4.4 | · | 3.7 | 3.6 | 3.2 | · | 3.1 | 3.0 | 2.7 | · | 2.6 | 2.2 | |
| Quick Ratio | 1.8 | · | 1.8 | 2.4 | 2.8 | · | 2.1 | 2.0 | 1.8 | · | 1.9 | 1.7 | 1.4 | · | 1.5 | 1.2 | |
| Debt / Equity | 1.1 | · | · | · | · | · | 0.6 | 0.6 | 0.7 | · | 0.8 | 0.8 | 0.9 | · | 0.9 | 0.9 | |
| LT Debt / Equity | 1.0 | · | · | · | · | · | 0.6 | 0.6 | 0.7 | · | 0.8 | 0.8 | 0.9 | · | 0.9 | 0.9 |
Eficiencia
| Métrica | Tendencia | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | |
| Inventory Turnover | 0.8 | · | 0.8 | 0.8 | 0.7 | · | 0.9 | 0.8 | 0.8 | · | 0.8 | 0.8 | 0.8 | · | 0.9 | 1.0 | |
| Receivables Turnover | 1.5 | · | 1.6 | 1.5 | 1.5 | · | 1.7 | 1.8 | 1.6 | · | 1.7 | 1.9 | 1.8 | · | 1.9 | 2.0 |
Por Acción
| Métrica | Tendencia | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $34.04 | · | $32.55 | $32.48 | $33.03 | · | $31.97 | $31.05 | $30.17 | · | $28.93 | $27.78 | $26.81 | · | $30.75 | $29.62 | |
| Revenue / Share | $5.58 | · | $5.89 | $5.56 | $5.01 | · | $5.81 | $5.68 | $5.31 | · | $5.64 | $5.72 | $5.56 | · | $5.49 | $5.75 | |
| Cash Flow / Share | $1.49 | · | · | · | $1.59 | · | · | · | $1.09 | · | · | · | $0.96 | · | · | · | |
| Cash / Share | $1.58 | · | $1.11 | $2.12 | $2.48 | · | $0.91 | $0.92 | $0.61 | · | $1.15 | $1.09 | $0.99 | · | $1.57 | $0.78 | |
| EPS (TTM) | $3.57 | · | $3.78 | $4.03 | $4.26 | · | $4.27 | $4.11 | $4.09 | · | $-1.61 | $-1.63 | $-1.68 | · | $4.17 | $4.12 |
Valoración (TTM)
| Métrica | Tendencia | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.10B | · | $1.10B | $1.11B | $1.12B | · | $1.12B | $1.11B | $1.11B | · | $1.13B | $1.13B | $1.13B | · | $1.11B | $1.11B | |
| Net Income TTM | $172M | · | $187M | $201M | $213M | · | $214M | $206M | $205M | · | $-81M | $-82M | $-84M | · | $210M | $209M | |
| Market Cap | $2.66B | · | $3.47B | $3.51B | $4.49B | · | $4.37B | $4.02B | $3.84B | · | $3.39B | $3.16B | $3.28B | · | $3.43B | $2.73B | |
| Enterprise Value | $4.59B | · | · | · | · | · | $5.32B | $5.03B | $4.90B | · | $4.53B | $4.38B | $4.56B | · | $4.79B | $4.14B | |
| P/E | 13.2 | · | 16.3 | 15.5 | 18.7 | · | 18.3 | 17.5 | 16.8 | · | -38.0 | -35.1 | -35.4 | · | 15.0 | 12.1 | |
| P/S | 2.4 | · | 3.1 | 3.2 | 4.0 | · | 3.9 | 3.6 | 3.4 | · | 3.0 | 2.8 | 2.9 | · | 3.1 | 2.5 | |
| P/B | 1.4 | · | 1.9 | 1.9 | 2.4 | · | 2.4 | 2.3 | 2.3 | · | 2.1 | 2.1 | 2.2 | · | 2.0 | 1.7 | |
| P / Cash Flow | 37.6 | · | · | · | 56.8 | · | · | · | 70.0 | · | · | · | 68.2 | · | · | · | |
| EV / Revenue | 4.2 | · | · | · | · | · | 4.8 | 4.5 | 4.4 | · | 4.0 | 3.9 | 4.0 | · | 4.3 | 3.7 | |
| Earnings Yield | 7.5% | · | 6.1% | 6.5% | 5.3% | · | 5.5% | 5.7% | 5.9% | · | -2.6% | -2.9% | -2.8% | · | 6.7% | 8.3% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Ingresos | $1.09B | $1.14B | $1.13B | $1.13B | $1.09B |
| Margen Bruto % | 54.7% | 55.8% | 55.5% | 55.5% | 57.1% |
| Margen Operativo % | 28.4% | 29.6% | 30.4% | -2.0% | 30.4% |
| Beneficio neto | $190M | $215M | $209M | $-82M | $205M |
| EPS Diluido | $3.91 | $4.29 | $4.17 | $-1.65 | $4.04 |
| Métrica | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Deuda / Patrimonio | · | · | 0.7 | 0.9 | 0.9 |
| Ratio corriente | 3.6 | 4.2 | 3.2 | 2.4 | 2.0 |
| Ratio Rápido | 2.1 | 2.7 | 1.9 | 1.4 | 1.2 |
| Métrica | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | $246M | $243M | $239M | $222M | $250M |
Propietarios institucionales (13F) 340 declarantes · $2.9B total · A fecha de 30 de septiembre de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
340
Valor en tenencia
$2.9B
Nuevas posiciones
39
Posiciones cerradas
69
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 39 (-19 vs trimestre anterior) | 69 (+29 vs trimestre anterior) | 108 (-17 vs trimestre anterior) | 119 (-10 vs trimestre anterior) | +2.2M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| BlackRock, Inc. | $370 187 111 | 7 831 333 | 12,99% | Acciones |
| VANGUARD GROUP INC | $332 432 481 | 5 388 758 | 11,66% | Acciones |
| ARIEL INVESTMENTS, LLC | $230 143 970 | 4 868 711 | 8,07% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $133 553 822 | 2 825 340 | 4,69% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $125 802 061 | 2 661 291 | 4,41% | Acciones |
| FULLER & THALER ASSET MANAGEMENT, INC. | $110 225 175 | 2 331 821 | 3,87% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $101 013 343 | 2 136 944 | 3,54% | Acciones |
| STATE STREET CORP | $100 047 570 | 2 116 513 | 3,51% | Acciones |
| BRANDES INVESTMENT PARTNERS, LP | $96 953 606 | 2 051 060 | 3,40% | Acciones |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | $88 490 528 | 1 872 023 | 3,10% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $74 306 032 | 1 571 742 | 2,61% | Acciones |
| Allspring Global Investments Holdings, LLC | $61 257 112 | 1 271 950 | 2,15% | Acciones |
| MORGAN STANLEY | $58 800 671 | 1 243 931 | 2,06% | Acciones |
| NORDEA INVESTMENT MANAGEMENT AB | $39 252 108 | 828 628 | 1,38% | Acciones |
| NORTHERN TRUST CORP | $36 560 934 | 773 449 | 1,28% | Acciones |
| WESTWOOD HOLDINGS GROUP INC | $35 473 535 | 750 445 | 1,24% | Acciones |
| RICE HALL JAMES & ASSOCIATES, LLC | $32 601 741 | 689 692 | 1,14% | Acciones |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $31 134 811 | 658 659 | 1,09% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $30 922 805 | 654 174 | 1,08% | Acciones |
| UBS Group AG | $30 186 858 | 638 605 | 1,06% | Acciones |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $29 772 348 | 629 836 | 1,04% | Acciones |
| Boston Trust Walden Corp | $28 832 289 | 609 949 | 1,01% | Acciones |
| GOLDMAN SACHS GROUP INC | $27 725 541 | 586 536 | 0,97% | Acciones |
| CITADEL ADVISORS LLC | $26 667 701 | 564 157 | 0,94% | Acciones |
| BANK OF AMERICA CORP /DE/ | $26 277 109 | 555 894 | 0,92% | Acciones |
| RAYMOND JAMES FINANCIAL INC | $21 949 967 | 464 353 | 0,77% | Acciones |
| Leeward Investments, LLC - MA | $20 700 289 | 437 916 | 0,73% | Acciones |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $19 921 578 | 421 440 | 0,70% | Acciones |
| Invesco Ltd. | $19 209 111 | 406 370 | 0,67% | Acciones |
| Woodline Partners LP | $17 004 012 | 359 721 | 0,60% | Acciones |
| ARMISTICE CAPITAL, LLC | $15 882 720 | 336 000 | 0,56% | Acciones |
| Glenmede Investment Management, LP | $15 685 425 | 251 369 | 0,55% | Acciones |
| Bank of New York Mellon Corp | $15 375 752 | 325 275 | 0,54% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $14 837 438 | 313 887 | 0,52% | Acciones |
| D. E. Shaw & Co., Inc. | $14 832 286 | 313 778 | 0,52% | Acciones |
| WELLS FARGO & COMPANY/MN | $14 604 614 | 308 962 | 0,51% | Acciones |
| Nuveen, LLC | $14 012 435 | 296 434 | 0,49% | Acciones |
| Congress Wealth Management LLC / DE / | $13 030 320 | 163 185 | 0,46% | Acciones |
| PRINCIPAL FINANCIAL GROUP INC | $12 700 693 | 268 684 | 0,45% | Acciones |
| Tributary Capital Management, LLC | $11 958 554 | 252 984 | 0,42% | Acciones |
| Fisher Asset Management, LLC | $11 698 136 | 247 474 | 0,41% | Acciones |
| VICTORY CAPITAL MANAGEMENT INC | $11 013 816 | 232 998 | 0,39% | Acciones |
| PRUDENTIAL FINANCIAL INC | $10 251 209 | 216 865 | 0,36% | Acciones |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $10 122 871 | 214 150 | 0,36% | Acciones |
| JPMORGAN CHASE & CO | $10 050 950 | 207 249 | 0,35% | Acciones |
| Aristotle Capital Boston, LLC | $10 043 458 | 212 470 | 0,35% | Acciones |
| ENVESTNET ASSET MANAGEMENT INC | $9 983 703 | 211 206 | 0,35% | Acciones |
| FMR LLC | $9 951 172 | 210 518 | 0,35% | Acciones |
| GLENMEDE TRUST CO NA | $9 729 017 | 205 818 | 0,34% | Acciones |
| JENNISON ASSOCIATES LLC | $9 393 259 | 198 715 | 0,33% | Acciones |
Informantes de la empresa 50 insiders · 29 directivos · 18 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Ronald M. Lombardi | Chief Executive Officer | 7 de mayo de 2026 F | 373 465 | 0 | 0 | $0 |
| Matthew Mannelly | President and CEO | 1 de junio de 2015 M | 27 706 | 0 | 0 | $0 |
| Mark Pettie | Chairman and CEO | 3 de marzo de 2009 P | 177 168 | 0 | 0 | $0 |
| Frank Palantoni | CEO and President | 19 de mayo de 2006 P | 33 278 | 0 | 0 | $0 |
| Christine Sacco | CFO & COO | 2 de mayo de 2026 F | 57 374 | 0 | 0 | $0 |
| David S Marberger | Chief Financial Officer | 9 de mayo de 2016 A | 11 050 | 0 | 0 | $0 |
| Peter Anderson | Chief Financial Officer | 25 de mayo de 2010 D | 401 850 | 0 | 0 | $0 |
| Jeffrey Zerillo | Senior VP Operations | 11 de mayo de 2026 S | 41 810 | 0 | 7 | $-246 374 |
| Adel Mekhail | EVP, Marketing & Sales | 7 de mayo de 2026 F | 25 703 | 0 | 0 | $0 |
| William P'Pool | SVP, General Counsel & Corp Secretary | 4 de mayo de 2026 A | 28 149 | 0 | 0 | $0 |
| Jose Luis Rosado | SVP-Quality & Regulatory Affairs | 6 de enero de 2026 A | 3 436 | 0 | 0 | $0 |
| Mary Beth Fritz | SVP Quality & Regulatory | 7 de mayo de 2025 F | 17 051 | 0 | 0 | $0 |
| Timothy Connors | EVP, Sales & Marketing | 9 de mayo de 2019 F | 21 717 | 0 | 0 | $0 |
| Jean A Boyko | SVP, Science and Technology | 15 de mayo de 2018 M | 11 081 | 0 | 0 | $0 |
| Christopher Heye | Senior Vice President-Canada, Women's Health and Strategic Planning. | 7 de mayo de 2018 A | 8 150 | 0 | 0 | $0 |
| Thomas Hochuli | Vice President, Operations | 14 de agosto de 2017 F | 6 678 | 0 | 0 | $0 |
| John Parkinson | Senior VP- International | 12 de mayo de 2017 F | 62 075 | 0 | 0 | $0 |
| Paul Migaki | VP of Strategic Planning/Canada | 27 de mayo de 2016 M | 55 927 | 0 | 0 | $0 |
| Samuel C Cowley | General Counsel and VP | 27 de mayo de 2016 M | 32 176 | 0 | 0 | $0 |
| Paul A. Hennessey | Vice President, Operations | 21 de mayo de 2014 M | 15 282 | 0 | 0 | $0 |
| Eric S. Klee | Secretary and General Counsel | 30 de mayo de 2011 F | 13 236 | 0 | 0 | $0 |
| David Talbert | Senior Vice President, Sales | 25 de mayo de 2010 D | 28 331 | 0 | 0 | $0 |
| Lieven Nuyttens | Senior VP, Operations | 25 de mayo de 2010 D | 16 640 | 0 | 0 | $0 |
| Charles Jolly | Secretary and General Counsel | 31 de marzo de 2009 D | 30 579 | 0 | 0 | $0 |
| Charles Schrank | Chief Mktg. Officer/Household | 31 de marzo de 2009 D | 90 846 | 0 | 0 | $0 |
| James E Kelly | SVP - Chief Marketing Officer | 30 de mayo de 2008 A | 27 427 | 0 | 0 | $0 |
| Gerard Butler | Chief Sales Officer | 2 de enero de 2007 D | 289 172 | 0 | 0 | $0 |
| Michael Fink | Senior V.P. of Marketing | 15 de febrero de 2005 S | 180 560 | 0 | 0 | $0 |
| Eric Millar | Senior V.P. of Operations | 15 de febrero de 2005 S | 72 347 | 0 | 0 | $0 |
| Sheila Hopkins | Consejero | 5 de agosto de 2025 A | 30 123 | 0 | 0 | $0 |
| Natale S Ricciardi | Consejero | 1 de agosto de 2023 A | 27 098 | 0 | 0 | $0 |
| COUGHLIN CHRISTOPHER J | Consejero | 2 de agosto de 2022 A | 13 218 | 0 | 0 | $0 |
| James M Jenness | Consejero | 4 de agosto de 2020 A | 22 791 | 0 | 0 | $0 |
| Carl J Johnson | Consejero | 31 de julio de 2018 A | 14 598 | 0 | 0 | $0 |
| Charles Hinkaty | Consejero | 4 de agosto de 2015 A | 31 714 | 0 | 0 | $0 |
| Patrick Lonergan | Consejero | 10 de diciembre de 2012 G | 37 323 | 0 | 0 | $0 |
| John Byom | Consejero | 3 de agosto de 2010 A | 29 755 | 0 | 0 | $0 |
| Vincent J Hemmer | Consejero | 10 de septiembre de 2009 J | 80 410 | 0 | 0 | $0 |
| Peter Mann | Consejero | 4 de agosto de 2009 A | 447 700 | 0 | 0 | $0 |
| Dick L Buell | Consejero | 4 de agosto de 2009 A | 27 662 | 0 | 0 | $0 |
| David Donnini | Consejero | 29 de mayo de 2009 S | 0 | 0 | 0 | $0 |
| Ronald B Gordon | Consejero | 5 de agosto de 2008 A | 30 352 | 0 | 0 | $0 |
| Raymond Silcock | Consejero | 5 de agosto de 2008 A | 16 249 | 0 | 0 | $0 |
| John F. Kelly | · | 4 de agosto de 2026 A | 7 832 | 0 | 0 | $0 |
| James Darecca | · | 4 de agosto de 2026 A | 9 572 | 0 | 0 | $0 |
| Dawn M. Zier | · | 4 de agosto de 2026 A | 19 514 | 0 | 0 | $0 |
| Celeste A. Clark | · | 4 de agosto de 2026 A | 16 511 | 0 | 0 | $0 |
| John E Byom | · | 4 de agosto de 2026 A | 54 575 | 0 | 1 | $-178 050 |
| COSTLEY GARY E | · | 4 de agosto de 2020 A | 50 200 | 0 | 0 | $0 |
| GTCR GOLDER RAUNER II LLC | · | 29 de mayo de 2009 S | 0 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 67 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| PJP · Invesco Exchange-Traded Fund Trust | 2,83% | 347 516 SH | 2 de octubre de 2026 | Diario |
| PILL · Direxion Shares ETF Trust | 1,16% | 4 781 NS | 31 de julio de 2026 | N-PORT |
| PSCH · Invesco Exchange-Traded Fund Trust … | 1,16% | 44 987 SH | 2 de octubre de 2026 | Diario |
| HSMV · First Trust Exchange-Traded Fund III | 0,80% | 5 597 NS | 31 de julio de 2026 | N-PORT |
| FYT · First Trust Exchange-Traded AlphaDE… | 0,65% | 25 280 NS | 31 de julio de 2026 | N-PORT |
| SCOW · Pacer Funds Trust | 0,59% | 201 NS | 31 de julio de 2026 | N-PORT |
| CAFG · Pacer Funds Trust | 0,52% | 3 105 NS | 31 de julio de 2026 | N-PORT |
| IHE · iShares Trust | 0,51% | 175 342 SH | 11 de septiembre de 2026 | Diario |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,34% | 92 272 NS | 31 de julio de 2026 | N-PORT |
| CALF · Pacer Funds Trust | 0,25% | 181 211 NS | 31 de julio de 2026 | N-PORT |
| VIOV · VANGUARD ADMIRAL FUNDS | 0,24% | 100 520 SH | 19 de agosto de 2026 | Diario |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0,16% | 18 534 NS | 31 de julio de 2026 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,15% | 41 965 SH | 19 de agosto de 2026 | Diario |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0,14% | 7 601 SH | 2 de octubre de 2026 | Diario |
| FAB · First Trust Exchange-Traded AlphaDE… | 0,13% | 4 372 NS | 31 de julio de 2026 | N-PORT |
| VIOO · VANGUARD ADMIRAL FUNDS | 0,12% | 165 811 SH | 19 de agosto de 2026 | Diario |
| ROSC · Lattice Strategies Trust | 0,12% | 1 466 NS | 31 de julio de 2026 | N-PORT |
| DFSV · Dimensional ETF Trust | 0,12% | 195 077 NS | 31 de julio de 2026 | N-PORT |
| PDN · Invesco Exchange-Traded Fund Trust … | 0,12% | 8 172 SH | 2 de octubre de 2026 | Diario |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,11% | 66 578 SH | 2 de octubre de 2026 | Diario |
| EBIT · Harbor ETF Trust | 0,11% | 258 NS | 31 de julio de 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,10% | 1 747 NS | 31 de julio de 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0,09% | 43 685 NS | 31 de julio de 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,09% | 11 789 NS | 31 de julio de 2026 | N-PORT |
| VFMV · VANGUARD WELLINGTON FUND | 0,08% | 7 246 SH | 19 de agosto de 2026 | Diario |
| RSSL · Global X Funds | 0,08% | 22 923 NS | 31 de julio de 2026 | N-PORT |
| IWM · iShares Trust | 0,07% | 1 227 360 SH | 11 de septiembre de 2026 | Diario |
| VSS · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,07% | 175 325 SH | 19 de agosto de 2026 | Diario |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,07% | 275 721 SH | 19 de agosto de 2026 | Diario |
| DFAT · Dimensional ETF Trust | 0,07% | 196 959 NS | 31 de julio de 2026 | N-PORT |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0,07% | 28 777 SH | 2 de octubre de 2026 | Diario |
| VBR · VANGUARD INDEX FUNDS | 0,05% | 690 582 SH | 19 de agosto de 2026 | Diario |
| DFAS · Dimensional ETF Trust | 0,05% | 152 317 NS | 31 de julio de 2026 | N-PORT |
| IGRO · iShares Trust | 0,05% | 10 967 SH | 11 de septiembre de 2026 | Diario |
| WSML · iShares Trust | 0,04% | 5 420 SH | 11 de septiembre de 2026 | Diario |
| FHLC · FIDELITY COVINGTON TRUST | 0,03% | 22 700 NS | 31 de julio de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,03% | 544 134 SH | 19 de agosto de 2026 | Diario |
| VB · VANGUARD INDEX FUNDS | 0,03% | 1 087 231 SH | 19 de agosto de 2026 | Diario |
| VHT · VANGUARD WORLD FUND | 0,03% | 142 413 SH | 19 de agosto de 2026 | Diario |
| DFAC · Dimensional ETF Trust | 0,01% | 117 382 NS | 31 de julio de 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0,01% | 36 640 NS | 31 de julio de 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,01% | 5 233 NS | 31 de julio de 2026 | N-PORT |
| VXUS · VANGUARD STAR FUNDS | 0,01% | 688 472 SH | 19 de agosto de 2026 | Diario |
| VEA · VANGUARD TAX-MANAGED FUNDS | 0,01% | 453 610 SH | 19 de agosto de 2026 | Diario |
| VSGX · VANGUARD WORLD FUND | 0,01% | 9 203 SH | 19 de agosto de 2026 | Diario |
| IDEV · iShares Trust | 0,01% | 52 014 SH | 11 de septiembre de 2026 | Diario |
| DXUV · Dimensional ETF Trust | 0,01% | 829 NS | 31 de julio de 2026 | N-PORT |
| TILT · FlexShares Trust | 0,01% | 3 004 NS | 31 de julio de 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,01% | 4 442 NS | 31 de julio de 2026 | N-PORT |
| IXUS · iShares Trust | 0,01% | 56 667 SH | 11 de septiembre de 2026 | Diario |
| ITOT · iShares Trust | 0,00% | 69 137 SH | 11 de septiembre de 2026 | Diario |
| IWV · iShares Trust | 0,00% | 14 019 SH | 11 de septiembre de 2026 | Diario |
| DFAU · Dimensional ETF Trust | 0,00% | 6 651 NS | 31 de julio de 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 10 940 NS | 31 de julio de 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1 510 012 SH | 19 de agosto de 2026 | Diario |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,00% | 69 368 SH | 19 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 4 089 SH | 19 de agosto de 2026 | Diario |
| ESGV · VANGUARD WORLD FUND | 0,00% | 10 506 SH | 19 de agosto de 2026 | Diario |
| IJR · iShares Trust | · | 2 889 316 SH | 10 de septiembre de 2026 | Diario |
| IJS · iShares Trust | · | 422 466 SH | 8 de septiembre de 2026 | Diario |
| IWN · iShares Trust | · | 449 434 SH | 11 de septiembre de 2026 | Diario |
| XJR · iShares Trust | · | 6 541 SH | 31 de agosto de 2026 | Diario |
| SVAL · iShares Trust | · | 10 792 SH | 3 de septiembre de 2026 | Diario |
| ISCB · iShares Trust | · | 1 977 SH | 11 de septiembre de 2026 | Diario |
| ISCV · iShares Trust | · | 9 565 SH | 11 de septiembre de 2026 | Diario |
| SMLF · iShares Trust | · | 38 488 SH | 11 de septiembre de 2026 | Diario |
| SMMV · iShares Trust | · | 20 132 SH | 25 de agosto de 2026 | Diario |
PBH Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 10 analistas
COMPRA
Objetivo mediano
$70.00
+54,7%
3 30,0%
Compra fuerte
4 40,0%
Compra
3 30,0%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
5 analistas · 2026-10-03Objetivo medio $67.80 +49,8%
← Por Debajo de Todos los Objetivos
Precio Actual $45.26
Mín$55.00
Media$67.80
Máx$75.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| PBH | $3.33B | 15.2 | -4.3% | 17.5% | 10.2% | 54.7% |
| SUPN | $2.86B | -73.1 | 8.6% | -5.4% | -3.6% | · |
| AMRX | · | 57.3 | 8.1% | 2.4% | -80.0% | 36.9% |
| HRMY | $2.16B | 13.8 | 21.5% | 18.3% | 19.3% | 77.2% |
| GPCR | $14.78B | -86.9 | · | · | -12.3% | · |
| TRLV | · | · | -0.45% | -10.3% | -10.4% | 60.2% |
| TRVI | $1.61B | -39.1 | · | · | -22.4% | · |
| NUVB | $3.03B | -14.9 | 699.0% | -325.3% | -60.3% | · |
| SEPN | $1.25B | -25.3 | 4174.5% | -106.4% | -12.9% | · |
| LLY | · | 46.8 | 44.7% | 31.7% | 101.2% | · |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 6, 2026